Melanoma of the eye: Preclinical tests show path toward treatment

A preclinical study offers hope for treatment of uveal melanoma, a rare and deadly cancer of the eye. A small molecule inhibitor has been identified that dampens the potent drivers of this tumor. In mouse models, the inhibitor strongly limited primary disease in the eye and metastatic tumor dissemination to the liver, and animals survived longer, without overt side effects.

source https://www.sciencedaily.com/releases/2021/07/210714132016.htm